Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



SEL24 / MEN1703 in Patients With Acute Myeloid Leukemia

Leukemia

The purpose of the clinical trial is to identify the highest dose of SEL24 / MEN1703 drug with acceptable safety profile and that can be used in patients with Acute Myeloid Leukemia.
Leukemia
I/II
Strickland, Stephen
NCT03008187
VICCHEM16123

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: